Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study will look at two FDA approved medications that improve how the pancreas works in
patients with Type 2 Diabetes. In order to understand how these medications work in patients
with diabetes we must first measure the normal response in healthy volunteers without
diabetes. We will be looking at the body's normal physiological response to low blood sugar
and whether this will be modified by these medicationsThe hypothesis would be that
glimepiride induced insulin secretion will be inhibited by hypoglycemia.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center